Journal of Psychopharmacology
September 4, 2026
M. Nikolič, Tom Froese, Pedro A. M. Mediano et al.
Background: Psilocybin’s therapeutic potential is neurophysiologically characterized by acute alpha power reductions and increased entropy. However, the systematic time-course of these changes from administration through the 24-hour sub-acute phase remains poorly characterized. Methods: In a double-blind, placebo-controlled, crossover trial ( N = 20, 10 females), healthy participants received a...
medRxiv
August 31, 2026
Jonathan Huntley, Benjy Barnett, Daniel Bor et al.
preprint
Despite extensive knowledge of the progressive sequence of cognitive and functional deficits in Alzheimer's Disease (AD), the impact of neurodegeneration on the conscious experience of patients remains largely unexplored. Understanding how the content of consciousness, particularly perceptual awareness, changes with the progression of AD is crucial to enable meaningful person-centred care. This...
May 13, 2026
Robin Carhart-Harris, Richard J. Zeifman, Lorenzo Pasquini et al.
preprint
First-line dictionary definitions of ‘plasticity’ describe it as the ability (of a thing) to be shaped or molded; we call this ‘plasticity proper’. In neuroscience, however, ‘neural plasticity’ or ‘neuroplasticity’ is defined as an induced change in brain function or structure. These two plasticities are not the same. Several (but not all) popular biomarkers of neuroplasticity index part of an...
Nature Communications
May 5, 2026
T Lyons, M Spriggs, L Kerkelä et al.
19 citations
Psychedelics have robust effects on acute brain function and long-term behavior but whether they also cause enduring functional and anatomical brain changes is largely unknown. In an exploratory, placebo-controlled, within-subjects, electroencephalography (EEG), and magnetic resonance imaging (MRI) study in 28 healthy, entirely psychedelic-naive participants, anatomical and functional brain...
bioRxiv
April 21, 2026
A. Liardi, Daniel Bor, Fernando E. Rosas et al.
preprint
Recent advances have shown that the complexity of neural signals tracks global states of consciousness, such as wakefulness versus sleep. However, it is still unclear to what extent neural complexity reflects fine-grained changes in conscious content within the same global state. Here, we investigate how the complexity of brain signals is affected by increased perceptual clarity of a stimulus....
arXiv Preprint Archive
April 13, 2026
Adam B. Barrett, Borjan Milinkovic, Pedro A. M. Mediano et al.
The integrated information theory of consciousness (IIT) is uniquely ambitious in proposing a mathematical formula, derived from apparently fundamental properties of conscious experience, to describe the quantity and quality of consciousness for any physical system that possesses it. IIT has generated considerable debate, which has engendered some misunderstandings and misrepresentations. Here...
Hum Brain Mapp
2026
Henrik Röhr, Daniel A Atad, Fynn-Mathis Trautwein et al.
1 citation
The sense of self is a multidimensional feature of human experience. Different dimensions of self-experience can change drastically during altered states of consciousness induced through meditation or psychedelic drugs, as well as in a variety of mental disorders. Some experienced meditation practitioners are able to modulate their sense of self deliberately, which allows for a direct...
Transl Psychiatry
November 13, 2025
Kenneth Shinozuka, Katarina Jerotic, Pedro A. M. Mediano et al.
correction
Correction: Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.
October 1, 2025
Daniel Andrew Atad, Pedro A. M. Mediano, Fynn-Mathis Trautwein et al.
1 citation
preprint
A fundamental aspect of human experience is that of being a bounded and embodied agent. This basic sense of self typically operates implicitly, yet traditional contemplative accounts alongside recent work in philosophy, phenomenology and neuroscience suggests that it can be attenuated or even fully dissolved while retaining awareness. Here we present an extended analysis of data from a...
Cell Reports
July 22, 2025
George Blackburne, Rosalind McAlpine, Marco S. Fabus et al.
10 citations
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a psychedelic drug known for its uniquely profound effects on consciousness; however, it remains unknown how it affects the brain. We collected electroencephalography (EEG) data of 29 healthy individuals before and after inhaling a high dose (12-mg) of vaporized synthetic 5-MeO-DMT. We replicate results from rodents showing amplified low-frequency...
Scientific Reports
January 29, 2025
Richard J. Zeifman, Meg J. Spriggs, Hannes Kettner et al.
26 citations
The Relaxed Beliefs Under pSychedelics (REBUS) model proposes that serotonergic psychedelics decrease the precision weighting of neurobiologically-encoded beliefs. We conducted a preliminary examination of two psychological assumptions of REBUS: (a) psychedelics foster acute relaxation and post-acute revision of confidence in mental-health-relevant beliefs; which (b) facilitate positive...
Neuroscience of Consciousness
2025
Daniel A Atad, Pedro A. M. Mediano, Fernando E. Rosas et al.
10 citations
Recent years have seen growing interest in the use of metrics inspired by complexity science for the study of consciousness. Work in this field has shown remarkable results in discerning conscious from unconscious states, and in characterizing states of altered conscious experience following psychedelic intake as involving enhanced complexity. Here, we study the relationship between complexity...
Translational Psychiatry
December 4, 2024
Kenneth Shinozuka, Katarina Jerotic, Pedro A. M. Mediano et al.
17 citations
Serotonergic psychedelics induce altered states of consciousness and have shown potential for treating a variety of neuropsychiatric disorders, including depression and addiction. Yet their modes of action are not fully understood. Here, we provide a novel, synergistic understanding of psychedelics arising from systematic reviews and meta-analyses of three hierarchical levels of analysis: (1)...
bioRxiv (Cold Spring Harbor Laboratory)
October 7, 2024
George Blackburne, Rosalind McAlpine, Marco S. Fabus et al.
8 citations
preprint
Abstract 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a psychedelic drug known for its uniquely profound effects on subjective experience, reliably eradicating the perception of time, space, and the self. However, little is known about how this drug alters large-scale brain activity. We collected naturalistic electroencephalography (EEG) data of 29 healthy individuals before and after...
medRxiv
September 11, 2024
Marek Nikolič, Pedro A. M. Mediano, Tom Froese et al.
6 citations
preprint
Abstract Psilocybin is a classic psychedelic and a novel treatment for mood disorders. Psilocybin induces dose-dependent transient (4-6 hours) usually pleasant changes in perception, cognition, and emotion by non-selectively agonizing the 5-HT 2A receptors and negatively regulating serotonin reuptake, and long-term positive antidepressant effect on mood and well-being. Long-term effects are...
Elife
July 18, 2024
Andrea I. Luppi, Pedro A. M. Mediano, Fernando E. Rosas et al.
49 citations
How is the information-processing architecture of the human brain organised, and how does its organisation support consciousness? Here, we combine network science and a rigorous information-theoretic notion of synergy to delineate a 'synergistic global workspace', comprising gateway regions that gather synergistic information from specialised modules across the human brain. This information is...
Trends in Neurosciences
May 31, 2024
Andrea I. Luppi, Fernando E. Rosas, Pedro A. M. Mediano et al.
23 citations
Disentangling how cognitive functions emerge from the interplay of brain dynamics and network architecture is among the major challenges that neuroscientists face. Pharmacological and pathological perturbations of consciousness provide a lens to investigate these complex challenges. Here, we review how recent advances about consciousness and the brain's functional organisation have been driven...
ACS Chemical Neuroscience
February 7, 2024
Pedro A. M. Mediano, Fernando E. Rosas, Christopher Timmermann et al.
60 citations
Recent findings have shown that psychedelics reliably enhance brain entropy (understood as neural signal diversity), and this effect has been associated with both acute and long-term psychological outcomes, such as personality changes. These findings are particularly intriguing, given that a decrease of brain entropy is a robust indicator of loss of consciousness (e.g., from wakefulness to...
bioRxiv (Cold Spring Harbor Laboratory)
November 9, 2023
Fernando E. Rosas, Pedro A. M. Mediano, Christopher Timmermann et al.
14 citations
preprint
A growing body of work shows that autonomic signals provide a privileged evidence-stream to capture various aspects of subjective and neural states. This work investigates the potential for autonomic markers to track the effects of psychedelics — potent psychoactive drugs with important scientific and clinical value. For this purpose, we introduce a novel Bayesian framework to estimate the...
Preprints.org
July 21, 2023
Fran Hancock, Fernando E. Rosas, Mengsen Zhang et al.
16 citations
preprint
Healthy brain functioning depends on balancing stable integration between brain areas for effective coordinated functioning, with bursts of desynchronisation to allow subsystems to reconfigure and express functional specialisation. Metastability, a concept originated in statistical physics and dynamical systems theory, has been proposed as a key signature that characterises this balance....
June 28, 2023
Daniel Andrew Atad, Pedro A. M. Mediano, Fernando E. Rosas et al.
11 citations
preprint
Recent years have seen a growing interest in the use of measures inspired by complexity science for the study of consciousness. The work done in this field has shown remarkable results in discerning conscious from unconscious states, and in characterizing states of altered conscious experience following intake of psychedelic substances as involving enhanced complexity. However, the relationship...
Communications Biology
June 20, 2023
Joel Frohlich, Pedro A. M. Mediano, Francesco Bavato et al.
16 citations
Abstract Low-frequency (<4 Hz) neural activity, particularly in the delta band, is generally indicative of loss of consciousness and cortical down states, particularly when it is diffuse and high amplitude. Remarkably, however, drug challenge studies of several diverse classes of pharmacological agents—including drugs which treat epilepsy, activate GABA B receptors, block acetylcholine...
Neuroimage
June 1, 2023
Joel Frohlich, Tim Bayne, Julia S Crone et al.
When does the mind begin? Infant psychology is mysterious in part because we cannot remember our first months of life, nor can we directly communicate with infants. Even more speculative is the possibility of mental life prior to birth. The question of when consciousness, or subjective experience, begins in human development thus remains incompletely answered, though boundaries can be set using...
Scientific Reports
April 17, 2023
Rubén Herzog, Pedro A. M. Mediano, Fernando E. Rosas et al.
51 citations
Psychedelic drugs, including lysergic acid diethylamide (LSD) and other agonists of the serotonin 2A receptor (5HT2A-R), induce drastic changes in subjective experience, and provide a unique opportunity to study the neurobiological basis of consciousness. One of the most notable neurophysiological signatures of psychedelics, increased entropy in spontaneous neural activity, is thought to be of...
Neuroimage
February 11, 2023
Andrea I. Luppi, Pedro A. M. Mediano, Fernando E. Rosas et al.
High-level brain functions are widely believed to emerge from the orchestrated activity of multiple neural systems. However, lacking a formal definition and practical quantification of emergence for experimental data, neuroscientists have been unable to empirically test this long-standing conjecture. Here we investigate this fundamental question by leveraging a recently proposed framework known...